Aptevo Therapeutics Inc. (APVO) Operating cash flow 2016–2025
Aptevo Therapeutics Inc. (APVO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$25.6MFY2025 · since FY2016: -$36.9M → -$25.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$25.6M | -7.6% |
| FY2024 | -$23.8M | -102.8% |
| FY2023 | -$11.7M | +44.2% |
| FY2022 | -$21.0M | +3.0% |
| FY2021 | -$21.7M | +26.1% |
| FY2020 | -$29.3M | +30.8% |
| FY2019 | -$42.4M | +17.6% |
| FY2018 | -$51.4M | -23.7% |
| FY2017 | -$41.6M | -12.8% |
| FY2016 | -$36.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice